HUE051831T2 - Szájon át történõ deszenzitizálásra szolgáló földimogyoró-készítmények elõállítása - Google Patents

Szájon át történõ deszenzitizálásra szolgáló földimogyoró-készítmények elõállítása

Info

Publication number
HUE051831T2
HUE051831T2 HUE14776121A HUE14776121A HUE051831T2 HU E051831 T2 HUE051831 T2 HU E051831T2 HU E14776121 A HUE14776121 A HU E14776121A HU E14776121 A HUE14776121 A HU E14776121A HU E051831 T2 HUE051831 T2 HU E051831T2
Authority
HU
Hungary
Prior art keywords
peanut
preparations
preparation
oral desensitization
desensitization
Prior art date
Application number
HUE14776121A
Other languages
English (en)
Hungarian (hu)
Inventor
Bryan Walser
Howard Raff
Original Assignee
Aimmune Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51528061&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE051831(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aimmune Therapeutics Inc filed Critical Aimmune Therapeutics Inc
Publication of HUE051831T2 publication Critical patent/HUE051831T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Transplantation (AREA)
  • Medical Informatics (AREA)
  • Pulmonology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
HUE14776121A 2013-03-14 2014-03-12 Szájon át történõ deszenzitizálásra szolgáló földimogyoró-készítmények elõállítása HUE051831T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361784964P 2013-03-14 2013-03-14

Publications (1)

Publication Number Publication Date
HUE051831T2 true HUE051831T2 (hu) 2021-03-29

Family

ID=51528061

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE14776121A HUE051831T2 (hu) 2013-03-14 2014-03-12 Szájon át történõ deszenzitizálásra szolgáló földimogyoró-készítmények elõállítása

Country Status (19)

Country Link
US (5) US9198869B2 (cg-RX-API-DMAC10.html)
EP (3) EP3482771B1 (cg-RX-API-DMAC10.html)
JP (3) JP6752140B2 (cg-RX-API-DMAC10.html)
CN (2) CN109125283A (cg-RX-API-DMAC10.html)
AU (5) AU2014240404B2 (cg-RX-API-DMAC10.html)
BR (1) BR112015021756B1 (cg-RX-API-DMAC10.html)
CA (1) CA2903229A1 (cg-RX-API-DMAC10.html)
DK (2) DK2968529T3 (cg-RX-API-DMAC10.html)
ES (2) ES2826224T3 (cg-RX-API-DMAC10.html)
FI (2) FI3482771T3 (cg-RX-API-DMAC10.html)
FR (1) FR23C1026I2 (cg-RX-API-DMAC10.html)
HU (1) HUE051831T2 (cg-RX-API-DMAC10.html)
MX (1) MX2015010315A (cg-RX-API-DMAC10.html)
NL (1) NL301236I2 (cg-RX-API-DMAC10.html)
NO (1) NO2023027I1 (cg-RX-API-DMAC10.html)
PL (1) PL2968529T3 (cg-RX-API-DMAC10.html)
PT (1) PT2968529T (cg-RX-API-DMAC10.html)
SI (1) SI2968529T1 (cg-RX-API-DMAC10.html)
WO (1) WO2014159607A1 (cg-RX-API-DMAC10.html)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
MX2015010315A (es) 2013-03-14 2016-04-13 Aimmune Therapeutics Inc Fabricacion de formulaciones de mani para desensibilizacion oral.
WO2014159609A1 (en) 2013-03-14 2014-10-02 Allergen Research Corporation Peanut formulations and uses thereof
JP6910946B2 (ja) 2014-08-25 2021-07-28 アイミューン セラピューティクス,インコーポレイテッド タマゴのタンパク質製剤およびその製造方法
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
WO2016134291A2 (en) 2015-02-20 2016-08-25 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10143742B2 (en) 2015-02-20 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
TW201709926A (zh) * 2015-04-23 2017-03-16 賽諾菲公司 用於舌下投藥之吡喃葡萄糖基脂a及過敏原調配物
US10856567B2 (en) 2016-07-22 2020-12-08 Kari Brown Baby food products containing allergenic proteins and methods of delivering same
PT3548079T (pt) * 2016-12-05 2023-07-27 Reacta Biotech Ltd Formulações de refeições para provocação oral
CN110381749A (zh) * 2017-01-13 2019-10-25 艾慕恩治疗公司 坚果粉的制造方法和用于口服免疫疗法的配方
AU2017279647B2 (en) 2017-02-15 2022-05-26 Euroimmun Medizinische Labordiagnostika Ag An improved assay for the diagnosis of peanut allergy
CN111465328A (zh) 2017-07-18 2020-07-28 前品牌股份有限公司 制备混合型变应原组合物的方法
US11369676B2 (en) 2017-11-02 2022-06-28 Société des Produits Nestlé S.A. Methods of oral immunotherapy
GB201718342D0 (en) * 2017-11-06 2017-12-20 Cambridge Allergy Ltd Allergenic protein formulations for immunotherapy
EP3740223A4 (en) 2018-01-16 2021-10-20 Tel HaShomer Medical Research Infrastructure and Services Ltd. TREATMENT AND PREVENTION OF SEED ALLERGIES
US11406563B2 (en) 2018-07-27 2022-08-09 Société des Produits Nestlé S.A. Oral immunotherapy unit dose dispensing systems and methods
US12433945B2 (en) 2018-08-16 2025-10-07 Société des Produits Nestlé S.A. Peanut oral immunotherapy with maintenance dose
AU2019401576A1 (en) * 2018-12-17 2021-06-24 Société des Produits Nestlé S.A. Formulations for egg oral immunotherapy, methods of manufacture, and treatments for egg allergy
CA3123605A1 (en) * 2018-12-20 2020-06-25 Aimmune Therapeutics, Inc. Peanut oral immunotherapy dosing schedule for missed doses
US11766477B2 (en) 2019-01-23 2023-09-26 Societe Des Produits Nestle S.A. Methods for making mixed allergen compositions
CA3137295A1 (en) 2019-05-10 2020-11-19 Aimmune Therapeutics, Inc. Methods for improving the quality of life of a patient with a peanut allergy
ES3038192T3 (en) * 2019-08-08 2025-10-10 Evonik Operations Gmbh Method of preparing a solid dosage form and a lubricant
WO2021102186A1 (en) * 2019-11-20 2021-05-27 Aimmune Therapeutics, Inc. Methods and systems for managing distribution and treatment of a food allergy oral immunotherapy drug
AU2020410909A1 (en) * 2019-12-23 2022-07-14 Prota Therapeutics Pty Ltd Pharmaceutical compositions
JP7756664B2 (ja) 2020-07-01 2025-10-20 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 経口免疫療法のための医療スタッフ配置の決定
US20220220211A1 (en) 2021-01-08 2022-07-14 Regeneron Pharmaceuticals, Inc. Methods for treating peanut allergy and enhancing peanut allergen-specific immunotherapy by administering an il-4r antagonist
US20250325658A1 (en) 2022-04-11 2025-10-23 Alk-Abelló A/S Peanut allergen compositions

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3809767A (en) 1969-05-12 1974-05-07 Griffith Laboratories Methods of making vegetable protein concentrates
AU1589492A (en) 1991-03-01 1992-10-06 Warner-Lambert Company Starch-based controlled release compositions
US20120164306A1 (en) * 1993-08-03 2012-06-28 Girsh Leonard S Process for preparing hypoallergenic and reduced fat foods
JP3445593B2 (ja) * 1994-09-10 2003-09-08 株式会社林原生物化学研究所 ペプチドとその用途
US20020018778A1 (en) 1999-12-06 2002-02-14 Caplan Michael J. Passive desensitization
EP1272213B1 (en) * 2000-04-06 2006-03-08 SEER Pharmaceuticals, LLC. Microbial delivery system
CA2516291C (en) 2003-02-28 2012-02-14 Alk-Abello A/S Dosage form having a saccharide matrix
EP2545931A1 (en) 2004-03-19 2013-01-16 Herbs Spring, LLC Herbal therapy for the treatment of food allergy
WO2007075171A1 (en) 2005-12-28 2007-07-05 Teva Pharmaceutical Industries Ltd. Pharmaceutical formulations of fenofibrate having improved bioavailability
FR2924349B1 (fr) * 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
CN102215825A (zh) 2008-11-19 2011-10-12 安万托特性材料股份有限公司 可直接压制的颗粒状的基于微晶纤维素的赋形剂、其制备方法及应用
WO2010069595A1 (en) 2008-12-19 2010-06-24 Merz Pharma Gmbh & Co. Kgaa 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
US8329208B2 (en) * 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
EP2364690A1 (en) * 2010-02-12 2011-09-14 Centro De Ingenieria Genetica Y Biotecnologia Orally administrable pharmaceutical pellet of epidermal growth factor
JP5800527B2 (ja) 2010-03-30 2015-10-28 日東電工株式会社 安定化医薬組成物、安定化医薬組成物溶液製剤、フィルム状製剤及びフィルム状製剤の製造方法
AR081776A1 (es) 2010-06-30 2012-10-17 Novartis Ag Composiciones farmaceuticas que comprenden monohidrato de lactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1h-bencimidazol-2-il]-1h-quinolin-2-ona, proceso para la produccion de la composicion
CN101912364B (zh) * 2010-08-09 2015-07-15 刘会梅 银杏内酯b脂质体组合药物
GB201104537D0 (en) * 2011-03-17 2011-05-04 Cambridge Entpr Ltd Treatment for peanut allergy
EP2750705B1 (en) * 2011-08-31 2022-11-16 Perosphere Technologies Inc. Methods for effectively and rapidly desensitizing allergic patients
WO2013087119A1 (en) 2011-12-16 2013-06-20 Hal Allergy Holding B.V. Pharmaceutical formulations and the use thereof for the treatment of peanut allergy
MX2015010315A (es) 2013-03-14 2016-04-13 Aimmune Therapeutics Inc Fabricacion de formulaciones de mani para desensibilizacion oral.
WO2014159609A1 (en) 2013-03-14 2014-10-02 Allergen Research Corporation Peanut formulations and uses thereof
JP6910946B2 (ja) 2014-08-25 2021-07-28 アイミューン セラピューティクス,インコーポレイテッド タマゴのタンパク質製剤およびその製造方法
CN110381749A (zh) 2017-01-13 2019-10-25 艾慕恩治疗公司 坚果粉的制造方法和用于口服免疫疗法的配方
US11369676B2 (en) 2017-11-02 2022-06-28 Société des Produits Nestlé S.A. Methods of oral immunotherapy

Also Published As

Publication number Publication date
US11141352B2 (en) 2021-10-12
US20160030289A1 (en) 2016-02-04
FI3482771T3 (fi) 2023-04-03
FR23C1026I1 (fr) 2023-10-06
JP2016512537A (ja) 2016-04-28
JP2021073321A (ja) 2021-05-13
SI2968529T1 (sl) 2021-03-31
BR112015021756A2 (pt) 2017-07-18
AU2020202685A1 (en) 2020-05-14
EP3482771B1 (en) 2023-01-18
NO2023027I1 (no) 2023-07-06
AU2018222980A1 (en) 2018-09-20
ES2940686T3 (es) 2023-05-10
US20200129378A1 (en) 2020-04-30
US10449118B2 (en) 2019-10-22
BR112015021756A8 (pt) 2019-11-19
DK3482771T3 (da) 2023-03-20
MX2015010315A (es) 2016-04-13
DK2968529T3 (da) 2020-10-12
WO2014159607A1 (en) 2014-10-02
CN105101994B (zh) 2018-10-12
FR23C1026I2 (fr) 2024-07-26
EP2968529A1 (en) 2016-01-20
PT2968529T (pt) 2020-11-10
BR112015021756B1 (pt) 2023-01-10
ES2826224T3 (es) 2021-05-17
NL301236I2 (nl) 2025-07-31
US20180042816A1 (en) 2018-02-15
EP3482771A1 (en) 2019-05-15
AU2020202685B2 (en) 2022-01-20
HK1217660A1 (zh) 2017-01-20
EP2968529B1 (en) 2020-08-05
US9198869B2 (en) 2015-12-01
US20140271836A1 (en) 2014-09-18
PL2968529T3 (pl) 2021-04-19
EP3998080A1 (en) 2022-05-18
AU2016231523B2 (en) 2018-05-31
US20230120350A1 (en) 2023-04-20
CN109125283A (zh) 2019-01-04
AU2014240404A1 (en) 2015-09-17
CA2903229A1 (en) 2014-10-02
JP6752140B2 (ja) 2020-09-09
AU2022201858B2 (en) 2024-04-04
FIC20230022I1 (fi) 2023-07-04
EP2968529A4 (en) 2016-10-05
AU2022201858A1 (en) 2022-04-07
AU2016231523A1 (en) 2016-10-06
JP7454519B2 (ja) 2024-03-22
CN105101994A (zh) 2015-11-25
AU2014240404B2 (en) 2016-07-21
JP6891205B2 (ja) 2021-06-18
JP2019108357A (ja) 2019-07-04

Similar Documents

Publication Publication Date Title
DK3482771T3 (da) Fremstilling af jordnøddeformuleringer til oral desensibilisering
IL254985B (en) Positioning of components in a user interface
IL242394B (en) Cenicriviroc compositions and methods of making and using the same
BR112016003454A2 (pt) Uso de composto de metil bardoxolona
PL2969227T3 (pl) Formulacja octanu abirateronu
HUE040609T2 (hu) GLP-1 vegyületek orális adagolása
SI2858671T1 (sl) Formulacija protiteles
EP3010570A4 (en) CLINICAL INTERFACE
HUE051982T2 (hu) Anti-alfa-szinuklein antitestek és alkalmazási eljárások
DK3049441T3 (da) Anti-PDL1-antistofformuleringer
EP3821931C0 (en) ORONASAL PATIENT INTERFACE
EP2922514A4 (en) BI-RADIAL PATIENT INTERFACE
HUE041224T2 (hu) Deferasziroxot tartalmazó orális készítmények
HRP20180684T1 (hr) Kombinacija lijekova
HUE037048T2 (hu) Eljárások 4-cikloalkiloxibenzolszulfonamidok elõállítására
LT2981255T (lt) Empagliflozino terapiniai panaudojimo būdai
PT3089754T (pt) Formulações de vacina de dose única
HRP20190101T1 (hr) Terapeutske uporabe empagliflozina
EP2958994A4 (en) Vaccine composition
EP2961397A4 (en) TRANSDERMAL FORMULATIONS
HRP20181122T1 (hr) Postupak za pripremu jopamidola
FR3001759B1 (fr) Rouge aubagee de turbomachine
FI20135866L (fi) Mikrobiologinen keratiinin prosessointi
IL245167A0 (en) Slow-release solid oral compositions
HRP20181307T1 (hr) Postupak izrade zubne proteze